Latest News for: Tanabe

Edit

Mitsubishi Tanabe Pharma America to Present Healthcare Resource Utilization Data in RADICAVA ORS® (edaravone)-Treated ALS Patients at AMCP 2024

PR Newswire 15 Apr 2024
About Mitsubishi Tanabe Pharma CorporationMitsubishi Tanabe Pharma Corporation (MTPC), the pharma arm of Mitsubishi Chemical Group (MCG), is one of the oldest pharmaceutical companies in the world, founded in 1678.
Edit

Heparin Induced Thrombocytopenia Market to Witness Growth by 2032, Estimates DelveInsight | Mitsubishi Tanabe Pharma, ...

GetNews 12 Apr 2024
Heparin-induced Thrombocytopenia Market Report’s Key Highlights ... Mitsubishi Tanabe Pharma, Veralox Therapeutics, The Medicines Company, Canyon Pharma, and others Key Heparin-induced Thrombocytopenia Therapies ... Mitsubishi Tanabe Pharma VLX-1005 ... 1.
Edit

Mitsubishi Tanabe Pharma America to Showcase Breadth of Neurodegenerative Research at 2024 American Academy of Neurology Annual Meeting

PR Newswire 12 Apr 2024
About Mitsubishi Tanabe Pharma Corporation Mitsubishi Tanabe Pharma Corporation (MTPC), the pharma arm of Mitsubishi Chemical Group (MCG), is one of the oldest pharmaceutical companies in the world, founded in 1678.
Edit

RADICAVA ORS® as Orphan drug designation and approval in US (Mitsubishi Tanabe Pharma Corporation)

Public Technologies 09 Apr 2024
Mitsubishi Tanabe Pharma Corporation (Head Office ... is handled by Mitsubishi Tanabe Pharma America, Inc ... ■ About Mitsubishi Tanabe Pharma America, Inc. Based in Jersey City, N.J., Mitsubishi Tanabe Pharma America, Inc.
Edit

Announcement of Publication in The Lancet Neurology from the Clinical Study of Investigational ND0612 for Parkinson's Disease (Mitsubishi Tanabe Pharma Corporation)

Public Technologies 19 Mar 2024
Mitsubishi Tanabe Pharma Corporation (Head Office ... Development of investigational ND0612 is being led by NeuroDerm Ltd., a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC) ... If approved, Mitsubishi Tanabe Pharma America, Inc.
Edit

Additional Approval of SGLT2 inhibitor CANAGLU® OD Tablets~First OD Tablets of SGLT2 inhibitors in Japan~ (Mitsubishi Tanabe Pharma Corporation)

Public Technologies 18 Mar 2024
). March 18, 2024 ... Mitsubishi Tanabe Pharma Corporation (Head Office. Chuo-ku, Osaka; Representative. Director ... Mitsubishi Tanabe Pharma Corporation published this content on 18 March 2024 and is solely responsible for the information contained therein.
Edit

Mitsubishi Tanabe Pharma America Announces Publication of Positive Results from Phase 3 BouNDless Trial of Investigational ND0612 in People with Parkinson's Disease Experiencing Motor Fluctuations

PR Newswire 18 Mar 2024
About Mitsubishi Tanabe Pharma CorporationMitsubishi Tanabe Pharma Corporation (MTPC), the pharma arm of Mitsubishi Chemical Group (MCG), is one of the oldest pharmaceutical companies in the world, founded in 1678.
Edit

Mitsubishi Tanabe Pharma America Announces Presentations in Parkinson's Disease at 2024 International Conference on Alzheimer's ...

Victoria Advocate 04 Mar 2024
JERSEY CITY, N.J., March 4, 2024 /PRNewswire/ -- Mitsubishi Tanabe Pharma America, Inc ... Development of investigational ND0612 is being led by NeuroDerm, Ltd., a wholly-owned subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC).

Most Viewed

In this photo provided by the Mayor of Odesa Hennadii Trukhanov in Telegram, firefighters work on the site of a burning building after a Russian drone attack in Odesa, Ukraine, Tuesday, April 23, 2024.
AP / Mayor of Odesa Hennadii Trukhanov via AP
×